WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 302
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 372

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 10  10  10  10  10  10 
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years
Female 15-49 years

Number of reported case

(Click for retrospective incidence data for Nauru)
Diphtheria
Japanese encephalitis
Measles 11  300  10 
Mumps
Pertussis 166 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Nauru)
Vaccine year result method % card seen                                                
BCG 2006  98  DHS   95  98  99*  99*  99*  93 
DTP1 2006  98  DHS   95  80  98  99*  99*  85 
DTP3 2006  89  DHS   95  75  79  99*  99*  44 
DTP4          33 
IPV1          99* 
HepB_BD          98  99*  99*  99*  98 
HepB3          95  79  99*  99*  58 
Hib3          75  79  99*  99* 
JapEnc         
MCV1          65  96  99*  99* 
MCV2          49  81  99*  99* 
PCV1         
PCV3         
Pol3 2006  91  DHS   95  75  79  99*  99*  27 
Rota1         
Rota_last         
Rubella1          65  96  99*  99* 
TT2plus          24  99*  99* 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Nauru)
BCG 99  99  99  99  99  93  93 
DTP1 99  99  98  99  99  85  90 
DTP3 95  87  79  99  99  44  74 
HepB3 95  87  79  99  99  58 
HepB_BD 99  99  99  99  99  98 
Hib3 95  87  79  99  99 
MCV1 98  97  96  99  99 
MCV2 94  88  81  99  99 
PCV3
Pol3 95  87  79  99  99  27  74 
Rota_last

Number of districts in the country 14  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 6, 10, 14 week; 18 months; 4 years; Yes
DTwPHibHepB 6, 10, 14 weeks;
HepB birth; Yes
Influenza_Adult chronic diseases and other risk groups
Influenza_Pediatric chronic diseases and other risk groups
MR 12, 15 months; Yes
OPV 6, 10, 14 week; 18 months; 4 years; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No    No  No  Yes  No  Yes 
What years does the MYP cover? number             2008 to 2010 
Nº of districts with microplans that include activities to raise immunization coverage number         14     

System performance

Total Nº districts in country number 14    14    14 
Nº districts with DTP3 coverage >=80% number  
% of districts with DTP3 coverage >=80% From 0 to 100%   100  50   
Nº districts with measles (MCV1) coverage >=95% number           NA 
% of districts with MCV1 coverage >=95% From 0 to 100%          

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No    No  No  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No    No  No  Yes    No 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%       NA    75  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No    No  No  No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.